Hamburg, March 31, 2026 – Beiersdorf is doubling down on venture capital as a strategic lever to drive future growth through science-based innovation, launching the second generation of its corporate venture capital fund with a €100 million commitment. The new Skin Care Innovation Fund doubles the volume of the fund launched in 2020 and reinforces Beiersdorf’s ambition to lead innovation in skin care.
Beiersdorf Venture Capital focuses on companies operating across skin care and its core thesis fields: life sciences and biotechnology, sustainability, AI-enabled technologies, and digital health solutions. The fund invests globally from early- to growth-stage companies, with initial investments typically ranging from €0.5 million to €5 million.
“Breakthrough innovation in skin care is increasingly driven by the synergy between extensive in-house research expertise and the dynamic advancements of external scientific entrepreneurship,” said Dr. Gitta Neufang, Chief Research & Development Officer at Beiersdorf. “Through our Skin Care Innovation Fund, we connect scientific advances from startups with Beiersdorf’s global R&D capabilities to translate scientific progress into effective skin care solutions for consumers worldwide.”
“With our second, €100 million venture capital fund, we build on the conviction that pioneering ideas need both capital and the right partners,” said Ascan Voswinckel, Head of Beiersdorf Venture Capital. “In addition to funding, we provide access to Beiersdorf’s leading R&D expertise and global brand platforms, a combination that creates sustainable value for both sides. This comes together with a considerable innovation momentum in our key fields, leading to attractive investment opportunities, for example in longevity science or AI enabled actives discovery.”
Since 2020, Beiersdorf Venture Capital has built a portfolio of more than 15 leading companies across life science, sustainability, and digital health. Several portfolio companies have reached significant milestones, both in technology collaborations as well as financial value creation.
A portfolio highlight is S‑Biomedic, a Belgian leader in skin microbiome science. After a VC investment and a multi‑year strategic partnership, the technology was integrated into Beiersdorf’s microbiome design platform, where it is now a fundamental part of the global innovation pipeline in microbiome‑based skin care. The company eventually became part of Beiersdorf through acquisition.
In longevity science, the fund backs leading startups such as Vincere Biosciences, a specialist in mitophagy research, and Turbine, frontrunner of AI-based cell simulation, to explore scientifically validated approaches to skin aging.
Investments in DePoly’s PET recycling technology and Melt&Marble’s precision fermented lipids are an integral part of Beiersdorf's efforts to reduce emissions and support the development of more sustainable solutions along its value chain.
With the new Skin Care Innovation Fund, Beiersdorf significantly deepens its engagement in the global innovation ecosystem, investing early in transformative technologies and business models while strengthening its ability to translate frontier science into scalable skin care solutions.
Additional information can be found at vc.beiersdorf.com.
About Beiersdorf Venture Capital
Beiersdorf Venture Capital (BVC) is the corporate venture capital arm of Beiersdorf AG, one of the world’s leading skin care companies and home to brands including NIVEA, Eucerin, and La Prairie. BVC invests in innovative startups globally from seed to Series B stages across strategically relevant fields including life sciences, sustainability, AI and digital health solutions. In addition to capital investments, Beiersdorf seeks to jointly pioneer the future of skin care while creating mutual value through strategic collaboration and technology partnerships. By connecting the scientific depth, global scale, and market access of Beiersdorf with the agility and innovation of startups, BVC aims to accelerate breakthrough technologies from the laboratory to the consumer.
